|
|
FDADocs 5/9/2008 | 0 (0) | 22 | 0 | 0 | English
acute leukemia Conclusions/speculationsBackground??? Criteria for FDA approval: ???Live... University Medical Center Stephanie J. Lee, MD, MPH Dana-Farber Cancer Institute June 24, 2005 ASH/FDA ... more>>
FDADocs 5/9/2008 | 0 (0) | 26 | 0 | 0 | English
, FDA1Outline??? ??? ??? ??? Drug approval regulations Regular vs. accelerated approval...)2Requirements for Drug Approval??? Safety (FD&C Act 1938) ??? Efficacy (1962 amendment ... more>>
FDADocs 5/9/2008 | 0 (0) | 15 | 0 | 0 | English
cart be implemented without prior FDA approval Draft guidance on comparability protocols for small...Breakout Session: Changes Without Prior Approval April 22, 2003Goals and Oli>jectives ... more>>
FDADocs 5/9/2008 | 0 (0) | 20 | 0 | 0 | English
???A Bridge Over Troubled Waters??? Using Bridge to Transplant as Criteria for FDA Drug Approval.... - Don???t spend much money.Establishing the Playing FieldOverall Criteria for Approval ... more>>
FDADocs 5/9/2008 | 0 (0) | 28 | 0 | 0 | English
ABBOTT PRISM?? HBcore Summary Basis for ApprovalProduct Trade Name Proper Name Applicant ABBOTT PRISM??? HBcore Hepatitis B Virus Core Antigen (E. coli, Recombinant) Abbott Laboratories Dept. 49C ... more>>
FDADocs 5/9/2008 | 0 (0) | 15 | 0 | 0 | English
.1.5 Summary of Basis for ApprovalCOBAS AmpliScreen??? HIV-1 Test, v1.5 Summary of Basis for ApprovalDecember 20, 2002 BLA 125059/0Summary of Basis for Approval Page iRoche Molecular ... more>>
FDADocs 5/9/2008 | 0 (0) | 22 | 0 | 0 | English
Question PosedIs any other response besides complete remission (CR) acceptable as an endpoint for either full or accelerated approval of a new agent in the treatment of acute leukemia (AML or ALL ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 14 | 0 | 0 | English
approach to addressing medicines that are marketed without required FDA approval. Second, in a related...Questions and Answers about Unapproved Drugs and FDA???s Enforcement Action Against Carbinoxamine ... more>>
FDADocs 5/5/2008 | 0 (0) | 21 | 0 | 0 | English
SUMMARY BASIS FOR APPROVAL Submission Tracking Number: Biological Product Name: Manufacturer: 125010/0.0Fibrin Sealant (Human) OMRIX biopharmaceuticals Ltd., MDA Blood Bank, Sheba Hospital, POB ... more>>
ProfessionalDocument 8/19/2008 | 0 (0) | 32 | 0 | 0 | English
RequestersFOOD AND DRUG ADMINISTRATION Approval and Oversight of the Drug MifeprexGAO... congressional requestersAccountability Integrity ReliabilityApproval and Oversight of the Drug ... more>>
FDADocs 5/9/2008 | 0 (0) | 24 | 0 | 0 | English
DEPARTMENT OF HEALTH & HUMAN SERVICESPublic Health ServiceFood and Drug Administration Rockville, MD 20857NDA 20-414Commanding General U.S. Army Medical Research an... ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 35 | 0 | 0 | English
SUMMARYOF BASISFOR APPROVALProper Name:Hepatitis C Virus Encoded Antigen... 3.0 SIA Summary of Basis for Approval February, 1999TABLE OF CONTENTS SECTION I. II. III ... more>>
FDADocs 5/9/2008 | 0 (0) | 23 | 0 | 0 | English
Summary Basis of ApprovalCalifornia Department of Health Services Botulism Immune Globulin Intravenous (Human) (BIG-IV) Biologics License ApplicationSUMMARY BASIS OF APPROVAL Botulism Immune ... more>>
|